In this study, we compared the dose-volume parameters for treatment of thoracic esophageal cancer with treatment plans for 3D-CRT, IMRT, IMAT and HT. 15 thoracic esophagus patients who were treated in our clinic between 2017-2018 years were selected. PTV volumes were between 205 and 445.4 cc with an average of 355.2 cc. 3D-CRT, IMRT, IMAT and HT radiotherapy plans were created for each patient using the same contours and the same dose planning prescription. Total dose of 50.4 Gy for all patients was planed with 180 cGy dose per a fraction in total 28 fractions. For PTV; when the four treatment techniques were compared, HI values were 3D-CRT 0.84 ± 0.0, IMRT 0.57 ± 0.05, IMAT 0.06 ± 0.013, HT 0.08 ± 0.03 (p <0.05). CI values were found for 3D-CRT as 1.84 ± 0.2, for IMRT as 1.25 ± 0.05, for IMAT as 1.19 ± 0.04, for HT as 1.2 ± 0.06 (p <0.05). IMRT and IMAT techniques provided better OAR protection compared to other techniques in all lung and heart comparisons. The lowest doses for Dmax and D1% of Spinal Cord were provided by HT technique. We found that IMRT, IMAT and HT techniques have lower critical organ doses than 3D-CRT technique for treating torasic esophageal cancer. Considering the current evidence of the relationship between radiation-induced cardiac toxicity in the literature and the dose-volume parameters after treatment for esophageal cancer in our study, we can say that dose plans are better for IMRT and IMAT plans than 3D-CRT and HT in terms of lung and heart doses.
18 January 2024 in Indian Journal of Clinical Biochemistry
Objectives: Although radiation therapy has been used for more than a hundred years, its definitive mechanism of action is not known. Many studies indicate that radiation induces free radicals which damage DNA. However, irradiation should also affect the collagen connective tissue matrix. This database analysis aims to determine the extent of DNA versus collagen perception in scientific papers. Methods: Journals indexed in PubMed were searched on March 3, 2022, using the medical keywords "cancer", "radiation therapy", "radiation therapy AND damage," radiation therapy AND mechanism AND damage, "radiation therapy AND clinical". The number of items found for each search was proportioned in terms of “DNA versus collagen” and the ratio was accepted as the perception shift coefficient. Results: Results were tested with the p-value analysis to calculate the difference between the two proportions in both search items. Based on the main rule under the assumption that “all cells have DNA and all cells live in the collagen matrix”. In the p1-p2 analysis of the data, a significant (p < 0.001) difference was obtained for all dichotomy scans. Conclusions: This data analysis supports the argument that both cancer and radiation therapy perception is DNA-based rather than collagen, since the synthesis and degradation process of very slow; it is not possible to observe it in short-term studies. The effects of irradiation should be further analyzed in this manner for purpose of collagen matrix interaction.
3 December 2025 in International Journal of Clinical Oncology and Cancer Research
Radiotherapy (RT) remains one of the most essential and effective modalities in cancer treatment, administered to more than half of all patients for both curative and palliative purposes. Despite remarkable technological advances in precision targeting and dose modulation, radiation-induced skin injuries (RISIs) remain among the most common and distressing side effects of RT, affecting approximately 85-95% of patients. These cutaneous toxicities—ranging from transient erythema and dry desquamation to severe ulceration, fibrosis, and necrosis—reflect complex cellular and molecular disruptions. The clinical management of RISIs remains inconsistent, with no universally accepted standard of care. While traditional topical agents and dressings provide symptomatic relief, their efficacy is limited by poor stability and insufficient antioxidant activity. Recent evidence underscores the promise of targeted molecular therapies—such as TGF-β/Smad3 and COX-2 inhibition—alongside regenerative approaches involving mesenchymal stem cells, biomaterials, and nanotechnology-based drug delivery systems. Furthermore, integrating predictive biomarkers may enable personalized prevention and treatment strategies. This review synthesizes current insights into the pathophysiological and molecular mechanisms of RISIs, highlighting both established and emerging therapeutic modalities. By bridging mechanistic understanding with translational innovation, it aims to inform the development of more effective, biologically guided interventions that mitigate toxicity, enhance tissue repair, and ultimately improve the quality of life and treatment outcomes for cancer patients.
Introduction:: The aim of the study was to develop deep-learning neural networks to guide treatment decisions and for the accurate evaluation of tumor response to neoadjuvant chemoradiotherapy (nCRT) in rectal cancer using magnetic resonance (MR) images. Methods:: Fifty-nine tumors with stage 2 or 3 rectal cancer that received nCRT were retrospectively evaluated. Pathological tumor regression grading was carried out using the Dworak (Dw-TRG) guidelines and served as the ground truth for response predictions. Imaging-based tumor regression grading was performed according to the MERCURY group guidelines from pre-treatment and post-treatment para-axial T2-weighted MR images (MR-TRG). Tumor signal intensity signatures were extracted by segmenting the tumors volumetrically on the images. Normalized histograms of the signatures were used as input to a deep neural network (DNN) housing long short-term memory (LSTM) units. The output of the network was the tumor regression grading prediction, DNN-TRG. Results:: In predicting complete or good response, DNN-TRG demonstrated modest agreement with Dw-TRG (Cohen’s kappa= 0.79) and achieved 84.6% sensitivity, 93.9% specificity, and 89.8% accuracy. MR-TRG revealed 46.2% sensitivity, 100% specificity, and 76.3% accuracy. In predicting a complete response, DNN-TRG showed slight agreement with Dw-TRG (Cohen’s kappa= 0.75) with 71.4% sensitivity, 97.8% specificity, and 91.5% accuracy. MR-TRG provided 42.9% sensitivity, 100% specificity, and 86.4% accuracy. DNN-TRG benefited from higher sensitivity but lower specificity, leading to higher accuracy than MR-TRG in predicting tumor response. Conclusion:: The use of deep LSTM neural networks is a promising approach for evaluating the tumor response to nCRT in rectal cancer.